GB976096A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB976096A GB976096A GB3555561A GB3555561A GB976096A GB 976096 A GB976096 A GB 976096A GB 3555561 A GB3555561 A GB 3555561A GB 3555561 A GB3555561 A GB 3555561A GB 976096 A GB976096 A GB 976096A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- vitamin
- unit dosage
- compositions
- excipients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Compositions in solid unit dosage form for oral administration in the treatment of rheumatic diseases comprise from 20 to 150 mg. of Vitamin D per unit dosage and, optionally, cholic acid and Vitamin B1. Examples relate to tablets comprising, in addition to the active ingredients, conventional diluents and excipients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3555561A GB976096A (en) | 1961-10-02 | 1961-10-02 | Pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3555561A GB976096A (en) | 1961-10-02 | 1961-10-02 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB976096A true GB976096A (en) | 1964-11-25 |
Family
ID=10379046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3555561A Expired GB976096A (en) | 1961-10-02 | 1961-10-02 | Pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB976096A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1198994A2 (en) * | 2000-10-20 | 2002-04-24 | Daicho Kikaku Incorporated Company | Health food products |
EP1281324A2 (en) * | 2001-07-31 | 2003-02-05 | Daicho Kikaku Incorporated Company | Health food products |
-
1961
- 1961-10-02 GB GB3555561A patent/GB976096A/en not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1198994A2 (en) * | 2000-10-20 | 2002-04-24 | Daicho Kikaku Incorporated Company | Health food products |
EP1198994A3 (en) * | 2000-10-20 | 2003-08-13 | Daicho Kikaku Incorporated Company | Health food products |
US6793943B2 (en) | 2000-10-20 | 2004-09-21 | Daicho Kikaku Incorporated Company | Health food products |
EP1281324A2 (en) * | 2001-07-31 | 2003-02-05 | Daicho Kikaku Incorporated Company | Health food products |
EP1281324A3 (en) * | 2001-07-31 | 2003-08-06 | Daicho Kikaku Incorporated Company | Health food products |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES488168A0 (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL OR MEDICINAL TABLETS FOR ORAL ADMINISTRATION, WITH DELAYED DELIVERY OF ACTIVE ACTIVE, IN TABLETS IN WHICH THE QUANTITY OF RELEASE OF THE ACTIVE AGENT IS DEFAULT. | |
YU48583B (en) | Process for preparation of the formulation in the form of pill for oral dosage | |
MX173567B (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION TO IMPROVE THE SYMPTOMS OF HIV-INDUCED DISEASE OR REDUCE HIV TRANSCRIPTION AND PROLIFERATION | |
GB984464A (en) | Therapeutic compositions comprising bromelain | |
KR910005858A (en) | Fatty acid therapy | |
ES370058A1 (en) | Antibiotic compositions | |
GB976096A (en) | Pharmaceutical compositions | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
ES294897A1 (en) | Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding) | |
FR2236488B1 (en) | ||
GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
KR830008678A (en) | Analgesic composition | |
GB1125924A (en) | Organic bismuth derivative | |
GB899059A (en) | Improvements in or relating to therapeutic compositions containing a pyridine derivative | |
SU133422A1 (en) | Medicinal product - rennet powder | |
GB810378A (en) | Fungicidal compositions containing griseofulvin | |
GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
GB911179A (en) | Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone | |
GB1174362A (en) | Oral Medicants for Haemorrhoids. | |
GB994733A (en) | New anabolically effective pharmaceutical preparations | |
ES345583A1 (en) | Indole Derivatives | |
ES352458A1 (en) | PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PROTEANABILIZING ACTION. | |
GB1269616A (en) | Improvements in pharmaceutical compositions | |
AU414340B2 (en) | Medicinal compositions for administration to animals and process for administering same | |
GB830868A (en) | Compositions for treating animals to eliminate hookworms and ascarids |